{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T22:57:01Z","timestamp":1786834621143,"version":"build-2736575974"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.bioorg.2024.107740","type":"journal-article","created":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T16:42:32Z","timestamp":1724344952000},"page":"107740","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Rational design of 2-benzylsulfinyl-benzoxazoles as potent and selective indoleamine 2,3-dioxygenase 1 inhibitors to combat inflammation"],"prefix":"10.1016","volume":"152","author":[{"given":"Ting","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiufeng","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangzhonghui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dali","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaqing","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6349","key":"10.1016\/j.bioorg.2024.107740_b0005","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf9794","article-title":"Tryptophan's metabolites in exercise, inflammation, and mental health","volume":"357","author":"Cervenka","year":"2017","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.bioorg.2024.107740_b0010","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41573-019-0016-5","article-title":"Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond","volume":"18","author":"Platten","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2024.107740_b0015","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.semcdb.2015.03.002","article-title":"The kynurenine pathway and neurodegenerative disease","volume":"40","author":"Maddison","year":"2015","journal-title":"Semin. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107740_b0020","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.tips.2020.11.006","article-title":"Tryptophan metabolism as a pharmacological target","volume":"42","author":"Modoux","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bioorg.2024.107740_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.108055","article-title":"Recent advances in clinical trials targeting the kynurenine pathway","volume":"236","author":"Pires","year":"2022","journal-title":"Pharmacol. Therap."},{"key":"10.1016\/j.bioorg.2024.107740_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2019.110820","article-title":"IDO activation, inflammation and musculoskeletal disease","volume":"131","author":"Ogbechi","year":"2020","journal-title":"Exp. Gerontol."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107740_b0035","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.it.2016.01.002","article-title":"IDO in the tumor microenvironment: inflammation, counter-regulation, and tolerance","volume":"37","author":"Munn","year":"2016","journal-title":"Trends Immunol."},{"issue":"5","key":"10.1016\/j.bioorg.2024.107740_b0040","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1172\/JCI31178","article-title":"Indoleamine 2,3-dioxygenase and tumor-induced tolerance","volume":"117","author":"Munn","year":"2007","journal-title":"J. Clin. Invest."},{"issue":"6\u20137","key":"10.1016\/j.bioorg.2024.107740_b0045","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3109\/08820139.2012.689405","article-title":"Host indoleamine 2,3-dioxygenase: contribution to systemic acquired tumor tolerance","volume":"41","author":"Johnson","year":"2012","journal-title":"Immunol. Invest."},{"issue":"4","key":"10.1016\/j.bioorg.2024.107740_b0050","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/S0021-9258(19)77982-4","article-title":"Mechanism of interferon-gamma action - characterization of indoleamine 2,3-dioxygenase in cultured human-cells induced by interferon-gamma and evaluation of the enzyme-mediated tryptophan degradation in its anticellular activity","volume":"263","author":"Takikawa","year":"1988","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2024.107740_b0055","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.4049\/jimmunol.0803104","article-title":"Blockade of indoleamine 2,3-dioxygenase protects mice against lipopolysaccharide-induced endotoxin shock","volume":"182","author":"Jung","year":"2009","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.bioorg.2024.107740_b0060","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1096\/fasebj.5.11.1907934","article-title":"Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism","volume":"5","author":"Taylor","year":"1991","journal-title":"FASEB J."},{"issue":"7203","key":"10.1016\/j.bioorg.2024.107740_b0065","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nature07201","article-title":"Origin and physiological roles of inflammation","volume":"454","author":"Medzhitov","year":"2008","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bioorg.2024.107740_b0070","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nm0310-265","article-title":"Ido brings down the pressure in systemic inflammation","volume":"16","author":"Hofmann","year":"2010","journal-title":"Nat. Med."},{"issue":"7745","key":"10.1016\/j.bioorg.2024.107740_b0075","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/s41586-019-0947-3","article-title":"Singlet molecular oxygen regulates vascular tone and blood pressure in inflammation","volume":"566","author":"Stanley","year":"2019","journal-title":"Nature"},{"issue":"5380","key":"10.1016\/j.bioorg.2024.107740_b0080","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1126\/science.281.5380.1191","article-title":"Prevention of allogeneic fetal rejection by tryptophan catabolism","volume":"281","author":"Munn","year":"1998","journal-title":"Science"},{"issue":"15","key":"10.1016\/j.bioorg.2024.107740_b0085","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.2174\/092986711795656063","article-title":"The interplay between indoleamine 2,3-dioxygenase 1 (IDO1) and cyclooxygenase (COX)-2 in chronic inflammation and cancer","volume":"18","author":"Cesario","year":"2011","journal-title":"Curr. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2024.107740_b0090","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1073\/pnas.0508996103","article-title":"Crystal structure of human indoleamine 2,3-dioxygenase: Catalytic mechanism of O2 incorporation by a heme-containing dioxygenase","volume":"103","author":"Sugimoto","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bioorg.2024.107740_b0095","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1038\/s41467-017-01725-8","article-title":"Structural insights into substrate and inhibitor binding sites in human indoleamine 2,3-dioxygenase 1","volume":"8","author":"Lewis-Ballester","year":"2017","journal-title":"Nat. Commun."},{"issue":"20","key":"10.1016\/j.bioorg.2024.107740_b0100","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1002\/cmdc.202100253","article-title":"Structural Basis of selective human indoleamine-2,3-dioxygenase 1 (hIDO1) inhibition","volume":"16","author":"Kassab","year":"2021","journal-title":"ChemMedChem"},{"issue":"24","key":"10.1016\/j.bioorg.2024.107740_b0105","doi-asserted-by":"crossref","first-page":"17690","DOI":"10.1021\/acs.jmedchem.1c01665","article-title":"Structure and plasticity of indoleamine 2,3-dioxygenase 1 (IDO1)","volume":"64","author":"R\u00f6hrig","year":"2021","journal-title":"J. Med. Chem."},{"issue":"33","key":"10.1016\/j.bioorg.2024.107740_b0110","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.1021\/acs.biochem.7b00586","article-title":"The binding mode of N-hydroxyamidines to indoleamine 2,3-dioxygenase 1 (IDO1)","volume":"56","author":"R\u00f6hrig","year":"2017","journal-title":"Biochemistry-Us"},{"key":"10.1016\/j.bioorg.2024.107740_b0115","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2018.00370","article-title":"Indoximod: an immunometabolic adjuvant that empowers T cell activity in cancer","volume":"8","author":"Fox","year":"2018","journal-title":"Front. Oncol."},{"issue":"14","key":"10.1016\/j.bioorg.2024.107740_b0120","doi-asserted-by":"crossref","first-page":"6705","DOI":"10.1021\/acs.jmedchem.9b00662","article-title":"Discovery of clinical candidate(1R,4r)-4-((R)-2-((S)-6-fluoro-5-imidazo[5,1-a]isoindol-5-yl)-1-hydroxyethyl)cyclohexan-1-ol (navoximod), a potent and selective inhibitor of indoleamine 2,3-dioxygenase 1","volume":"62","author":"Kumar","year":"2019","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2024.107740_b0125","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1021\/acsmedchemlett.6b00391","article-title":"INCB24360 (Epacadostat), a highly potent and selective indoleamine-2,3-dioxygenase 1 (ID01) inhibitor for immunooncology","volume":"8","author":"Yue","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"issue":"23","key":"10.1016\/j.bioorg.2024.107740_b0130","doi-asserted-by":"crossref","first-page":"9617","DOI":"10.1021\/acs.jmedchem.7b00974","article-title":"Discovery of a novel and selective indoleamine 2,3-dioxygenase (IDO-1) inhibitor 3-(5-fluoro-1-indo1-3-yl)pyrrolidine-2,5-dione (EOS200271\/PF-06840003) and its characterization as a potential clinical candidate","volume":"60","author":"Crosignani","year":"2017","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107740_b0135","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1158\/1535-7163.MCT-20-0251","article-title":"Preclinical characterization of linrodostat mesylate, a novel, potent, and selective oral indoleamine 2,3-dioxygenase 1 inhibitor","volume":"20","author":"Balog","year":"2021","journal-title":"Mol. Cancer Ther."},{"issue":"24","key":"10.1016\/j.bioorg.2024.107740_b0140","doi-asserted-by":"crossref","first-page":"9421","DOI":"10.1021\/acs.jmedchem.5b00326","article-title":"Challenges in the discovery of indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors","volume":"58","author":"R\u00f6hrig","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107740_b0145","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1046818","article-title":"Indoleamine 2, 3-dioxygenase 1 inhibitory compounds from natural sources","volume":"13","author":"Tan","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107740_b0150","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1080\/14756366.2022.2089665","article-title":"Structure-based optimization of type III indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors","volume":"37","author":"R\u00f6hrig","year":"2022","journal-title":"J. Enzym. Inhib. Med Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107740_b0155","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1021\/jm0508888","article-title":"Structure-activity study of Brassinin derivatives as indoleamine 2,3-dioxygenase inhibitors","volume":"49","author":"Gaspari","year":"2006","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107740_b0160","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/0003-9861(91)90142-6","article-title":"1-Methyl-Dl-tryptophan, beta-(3-benzofuranyl)-DL-alanine (the oxygen analog of tryptophan), and beta-[3-benzo(b)thienyl]-DL-alanine (the sulfur analog of tryptophan) are competitive inhibitors for indoleamine 2,3-dioxygenase","volume":"291","author":"Cady","year":"1991","journal-title":"Arch. Biochem. Biophys."},{"issue":"21","key":"10.1016\/j.bioorg.2024.107740_b0165","doi-asserted-by":"crossref","first-page":"9760","DOI":"10.1021\/acs.jmedchem.6b00718","article-title":"New inhibitors of indoleamine 2,3-dioxygenase 1: molecular modeling studies, synthesis, and biological evaluation","volume":"59","author":"Coluccia","year":"2016","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2024.107740_b0170","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.bmc.2010.12.032","article-title":"Indol-2-yl ethanones as novel indoleamine 2,3-dioxygenase (IDO) inhibitors","volume":"19","author":"Dolusic","year":"2011","journal-title":"Bioorg. Med. Chem."},{"issue":"24","key":"10.1016\/j.bioorg.2024.107740_b0175","doi-asserted-by":"crossref","first-page":"7641","DOI":"10.1016\/j.bmcl.2012.10.010","article-title":"Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2","volume":"22","author":"Bakmiwewa","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"24","key":"10.1016\/j.bioorg.2024.107740_b0180","doi-asserted-by":"crossref","first-page":"7595","DOI":"10.1016\/j.bmc.2013.10.037","article-title":"Discovery and characterisation of hydrazines as inhibitors of the immune suppressive enzyme, indoleamine 2,3-dioxygenase 1 (IDO1)","volume":"21","author":"Fung","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107740_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111985","article-title":"Design, synthesis and biological evaluation of indole-2-carboxylic acid derivatives as IDO1\/TDO dual inhibitors","volume":"188","author":"Cui","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2024.107740_b0190","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24112124","article-title":"Design and synthesis of indoleamine 2,3-dioxygenase 1 inhibitors and evaluation of their use as anti-tumor agents","volume":"24","author":"Wen","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2024.107740_b0195","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.ejmech.2015.12.028","article-title":"O-alkylhydroxylamines as rationally-designed mechanism-based inhibitors of indoleamine 2,3-dioxygenase-1","volume":"108","author":"Malachowski","year":"2016","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2024.107740_b0200","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1039\/D0CB00209G","article-title":"Design, synthesis and evaluation of tryptophan analogues as tool compounds to study IDO1 activity","volume":"2","author":"Cundy","year":"2021","journal-title":"RSC Chem. Biol."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107740_b0205","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0021-9258(19)63693-8","article-title":"Studies on oxygenases; enzymatic formation of kynurenine from tryptophan","volume":"229","author":"Hayaishi","year":"1955","journal-title":"J. Biol. Chem."},{"issue":"41","key":"10.1016\/j.bioorg.2024.107740_b0210","doi-asserted-by":"crossref","first-page":"17371","DOI":"10.1073\/pnas.0906655106","article-title":"Evidence for a ferryl intermediate in a heme-based dioxygenase","volume":"106","author":"Lewis-Ballester","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"52","key":"10.1016\/j.bioorg.2024.107740_b0215","doi-asserted-by":"crossref","first-page":"30924","DOI":"10.1074\/jbc.M115.695684","article-title":"Substrate oxidation by indoleamine 2,3-dioxygenase","volume":"290","author":"Booth","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2024.107740_b0220","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1021\/jacs.0c09970","article-title":"Conformational plasticity in human heme-based dioxygenases","volume":"143","author":"Pham","year":"2021","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2024.107740_b0225","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1039\/a704025c","article-title":"A general synthesis of benzofuran-2-thiolates via intramolecular addition of phenolates to alkynethiolates","volume":"18","author":"Dhooge","year":"1997","journal-title":"Chem. Commun."},{"issue":"36","key":"10.1016\/j.bioorg.2024.107740_b0230","doi-asserted-by":"crossref","DOI":"10.1021\/ja9029768","article-title":"Inhibitory substrate binding site of human indoleamine 2,3-dioxygenase","volume":"131","author":"Lu","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2024.107740_b0235","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ejmech.2014.06.078","article-title":"Detailed analysis and follow-up studies of a high-throughput screening for indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors","volume":"84","author":"R\u00f6hrig","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107740_b0240","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.ejmech.2016.12.029","article-title":"Discovery and evaluation of inhibitors to the immunosuppressive enzyme indoleamine 2,3-dioxygenase 1 (IDO1): Probing the active site-inhibitor interactions","volume":"126","author":"Tomek","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"25","key":"10.1016\/j.bioorg.2024.107740_b0245","doi-asserted-by":"crossref","first-page":"7274","DOI":"10.1021\/jm061103g","article-title":"Interpreting steep dose-response curves in early inhibitor discovery","volume":"49","author":"Shoichet","year":"2006","journal-title":"J. Med. Chem."},{"issue":"20","key":"10.1016\/j.bioorg.2024.107740_b0250","doi-asserted-by":"crossref","first-page":"6089","DOI":"10.1021\/bi00368a038","article-title":"Spectroscopic and equilibrium properties of the indoleamine 2,3-dioxygenase tryptophan O-2 ternary complex and of analogous enzyme derivatives - tryptophan binding to ferrous enzyme adducts with dioxygen, nitric-oxide, and carbon-monoxide","volume":"25","author":"Sono","year":"1986","journal-title":"Biochemistry-Us"},{"issue":"28","key":"10.1016\/j.bioorg.2024.107740_b0255","doi-asserted-by":"crossref","first-page":"8527","DOI":"10.1021\/bi060143j","article-title":"Interactions between nitric oxide and indoleamine 2,3-dioxygenase","volume":"45","author":"Samelson-Jones","year":"2006","journal-title":"Biochemistry-Us"},{"issue":"47","key":"10.1016\/j.bioorg.2024.107740_b0260","doi-asserted-by":"crossref","first-page":"10081","DOI":"10.1021\/bi1009997","article-title":"A specific interaction of L-tryptophan with CO of CO-bound indoleamine 2,3-dioxygenase identified by resonance Raman spectroscopy","volume":"49","author":"Yanagisawa","year":"2010","journal-title":"Biochemistry-Us"},{"issue":"24","key":"10.1016\/j.bioorg.2024.107740_b0265","doi-asserted-by":"crossref","first-page":"5028","DOI":"10.1021\/bi1005078","article-title":"Spectroscopic studies of ligand and substrate binding to human indoleamine 2,3-dioxygenase","volume":"49","author":"Lu","year":"2010","journal-title":"Biochemistry-Us"},{"key":"10.1016\/j.bioorg.2024.107740_b0270","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-019-1083-5","article-title":"H2S suppresses indoleamine 2, 3-dioxygenase 1 and exhibits immunotherapeutic efficacy in murine hepatocellular carcinoma","volume":"38","author":"Yang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"23","key":"10.1016\/j.bioorg.2024.107740_b0275","doi-asserted-by":"crossref","first-page":"7364","DOI":"10.1021\/jm900518f","article-title":"Discovery of potent competitive inhibitors of indoleamine 2,3-dioxygenase with in vivo pharmacodynamic activity and efficacy in a mouse melanoma model","volume":"52","author":"Yue","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107740_b0280","article-title":"4,5-Disubstituted 1,2,3-triazoles: effective inhibition of indoleamine 2,3-dioxygenase 1 enzyme regulates T cell activity and mitigates tumor growth","volume":"9","author":"Panda","year":"2019","journal-title":"Sci. Rep.-Uk"},{"issue":"18","key":"10.1016\/j.bioorg.2024.107740_b0285","doi-asserted-by":"crossref","first-page":"9869","DOI":"10.1002\/anie.202016004","article-title":"Cell-based identification of new IDO1 modulator chemotypes","volume":"60","author":"Hennes","year":"2021","journal-title":"Angew. Chem. Int. Ed."},{"issue":"6","key":"10.1016\/j.bioorg.2024.107740_b0290","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1021\/acs.jmedchem.9b01809","article-title":"Discovery of highly potent benzimidazole derivatives as indoleamine 2,3-dioxygenase-1 (IDO1) inhibitors: from structure-based virtual screening to pharmacodynamic activity","volume":"63","author":"Serafini","year":"2020","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2024.107740_b0295","doi-asserted-by":"crossref","DOI":"10.1038\/nchembio.1337","article-title":"Metrics other than potency reveal systematic variation in responses to cancer drugs","volume":"9","author":"Fallahi-Sichani","year":"2013","journal-title":"Nat. Chem. Biol."},{"issue":"19","key":"10.1016\/j.bioorg.2024.107740_b0300","doi-asserted-by":"crossref","first-page":"8784","DOI":"10.1021\/acs.jmedchem.9b00942","article-title":"Inhibition mechanisms of indoleamine 2,3-dioxygenase 1 (IDO1)","volume":"62","author":"R\u00f6hrig","year":"2019","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2024.107740_b0305","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1021\/acs.jmedchem.9b01549","article-title":"Unique sulfur-aromatic interactions contribute to the binding of potent imidazothiazole indoleamine 2,3-dioxygenase inhibitors","volume":"63","author":"Peng","year":"2020","journal-title":"J. Med. Chem."},{"issue":"21","key":"10.1016\/j.bioorg.2024.107740_b0310","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107740_b0315","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1107\/S2053230X18012955","article-title":"High-resolution structures of inhibitor complexes of human indoleamine 2,3-dioxygenase 1 in a new crystal form","volume":"74","author":"Luo","year":"2018","journal-title":"Acta Crystallogr., F"},{"issue":"3","key":"10.1016\/j.bioorg.2024.107740_b0320","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1021\/bi901546e","article-title":"The selenazal drug ebselen potently inhibits indoleamine 2,3-dioxygenase by targeting enzyme cysteine residues","volume":"49","author":"Terentis","year":"2010","journal-title":"Biochemistry-Us"},{"issue":"6679","key":"10.1016\/j.bioorg.2024.107740_b0325","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1126\/science.adk5097","article-title":"Synthetic dioxygenase reactivity by pairing electrochemical oxygen reduction and water oxidation","volume":"383","author":"Hoque","year":"2024","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.bioorg.2024.107740_b0330","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1021\/acs.jmedchem.0c01968","article-title":"Azole-based indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors","volume":"64","author":"R\u00f6hrig","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107740_b0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107426","article-title":"Taking advantage of the interaction between the sulfoxide and heme cofactor to develop indoleamine 2, 3-dioxygenase 1 inhibitors","volume":"148","author":"Wang","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2024.107740_b0340","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1021\/cr400415k","article-title":"Heme enzyme structure and function","volume":"114","author":"Poulos","year":"2014","journal-title":"Chem. Rev."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107740_b0345","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/cbic.202000298","article-title":"Characterization of apo-form selective inhibition of indoleamine 2,3-dioxygenase","volume":"22","author":"Ortiz-Meoz","year":"2021","journal-title":"ChemBioChem"},{"issue":"13","key":"10.1016\/j.bioorg.2024.107740_b0350","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1073\/pnas.1719190115","article-title":"Immune-modulating enzyme indoleamine 2,3-dioxygenase is effectively inhibited by targeting its apo-form","volume":"115","author":"Nelp","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"14","key":"10.1016\/j.bioorg.2024.107740_b0355","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.3390\/molecules26144285","article-title":"Anti-inflammatory comparison of melatonin and its bromobenzoylamide derivatives in lipopolysaccharide (LPS)-induced RAW 264.7 cells and croton oil-induced mice ear edema","volume":"26","author":"Sangchart","year":"2021","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107740_b0360","doi-asserted-by":"crossref","first-page":"419","DOI":"10.4049\/jimmunol.159.1.419","article-title":"Differential regulation of indoleamine 2,3-dioxygenase expression by nitric oxide and inflammatory mediators in IFN-gamma-activated murine macrophages and microglial cells","volume":"159","author":"AlberatiGiani","year":"1997","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.bioorg.2024.107740_b0365","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0258204","article-title":"Characterizing the distributions of IDO-1 expressing macrophages\/microglia in human and murine brains and evaluating the immunological and physiological roles of IDO-1 in RAW264.7\/BV-2 cells","volume":"16","author":"Ji","year":"2021","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.bioorg.2024.107740_b0370","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1189\/jlb.68.2.260","article-title":"Combined inhibition of indoleamine 2,3-dioxygenase and nitric oxide synthase modulates neurotoxin release by interferon-\u03b3-activated macrophages","volume":"68","author":"Chiarugi","year":"2000","journal-title":"J. Leukoc. Biol."},{"issue":"5","key":"10.1016\/j.bioorg.2024.107740_b0375","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1128\/IAI.72.5.2723-2730.2004","article-title":"Nitric oxide-mediated regulation of gamma interferon-induced bacteriostasis: inhibition and degradation of human indoleamine 2,3-dioxygenase","volume":"72","author":"Hucke","year":"2004","journal-title":"Infect. Immun."},{"issue":"13","key":"10.1016\/j.bioorg.2024.107740_b0380","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.2174\/1389557520666200505124922","article-title":"Anticancer and antimicrobial activities of naproxen and naproxen derivatives","volume":"20","author":"Han","year":"2020","journal-title":"Mini-Rev. Med. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2024.107740_b0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011825","article-title":"Psychological stress-induced, IDO1-dependent tryptophan catabolism: implications on immunosuppression in mice and humans","volume":"5","author":"Kiank","year":"2010","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.bioorg.2024.107740_b0390","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1002\/ijc.31417","article-title":"1-L-MT, an IDO inhibitor, prevented colitis-associated cancer by inducing CDC20 inhibition-mediated mitotic death of colon cancer cells","volume":"143","author":"Liu","year":"2018","journal-title":"Int. J. Cancer"},{"issue":"21","key":"10.1016\/j.bioorg.2024.107740_b0395","doi-asserted-by":"crossref","first-page":"14348","DOI":"10.1021\/acs.jmedchem.2c00263","article-title":"Discovery of the first selective IDO2 inhibitor as novel immunotherapeutic avenues for rheumatoid arthritis","volume":"65","author":"He","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107740_b0400","article-title":"Severity of DSS-induced colitis is reduced in Ido1-deficient mice with down-regulation of TLR-MyD88-NF-kB transcriptional networks","volume":"5","author":"Shon","year":"2015","journal-title":"Sci. Rep.-Uk"},{"issue":"12","key":"10.1016\/j.bioorg.2024.107740_b0405","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1158\/1535-7163.MCT-17-1104","article-title":"Characterization of the selective lndoleamine 2,3-dioxygenase-1 (IDO1) catalytic inhibitor EOS200271\/PF-06840003 supports IDO1 as a critical resistance mechanism to PD-(L)1 blockade therapy","volume":"17","author":"Gomes","year":"2018","journal-title":"Mol. Cancer Ther."},{"issue":"6527","key":"10.1016\/j.bioorg.2024.107740_b0410","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1126\/science.abe7199","article-title":"Sex differences in immune responses","volume":"371","author":"Takahashi","year":"2021","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.bioorg.2024.107740_b0415","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1189\/jlb.3A1214-601RR","article-title":"Sexual dimorphisms in leukocyte trafficking in a mouse peritonitis model","volume":"98","author":"Kay","year":"2015","journal-title":"J. Leukoc. Biol."},{"issue":"18","key":"10.1016\/j.bioorg.2024.107740_b0420","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.3390\/ijms20184367","article-title":"Animal models of inflammation for screening of anti-inflammatory drugs: implications for the discovery and development of phytopharmaceuticals","volume":"20","author":"Patil","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2024.107740_b0425","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jep.2015.07.032","article-title":"Miller leaves present topical anti-inflammatory activity in models of acute and chronic dermatitis","volume":"173","author":"Pinto","year":"2015","journal-title":"J. Ethnopharmacol."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107740_b0430","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.sjbs.2015.10.004","article-title":"Evaluation of chemical composition and antiedematogenic activity of the essential oil of Hyptis martiusii Benth","volume":"24","author":"Barbosa","year":"2017","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.bioorg.2024.107740_b0435","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejmech.2018.10.017","article-title":"Tryptophan 2,3-dioxygenase inhibitory activities of tryptanthrin derivatives","volume":"160","author":"Zhang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2024.107740_b0440","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/j.bbapap.2011.07.023","article-title":"Purification and kinetic characterization of human indoleamine 2,3-dioxygenases 1 and 2 (IDO1 and IDO2) and discovery of selective IDO1 inhibitors","volume":"1814","author":"Meininger","year":"2011","journal-title":"BBA-Proteins Proteom."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682400645X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682400645X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T01:01:30Z","timestamp":1726016490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004520682400645X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":88,"alternative-id":["S004520682400645X"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107740","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rational design of 2-benzylsulfinyl-benzoxazoles as potent and selective indoleamine 2,3-dioxygenase 1 inhibitors to combat inflammation","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107740","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107740"}}